The task of injecting COVID-19 raises obvious questions, with one important question revolving around natural immunity. Your immune system is designed to work in response to exposure to an infectious agent. In particular, your adaptive immune system produces antibodies that are used to fight pathogens that your body has previously encountered.first
If you already have COVID-19, research shows that you are well protected against reinfection. New data from the US Centers for Disease Control and Prevention even shows that prior COVID-19 infection, i.e., innate immunity, is more protective than COVID-19 injections.2
However, people with natural immunity continue to be discriminated against and still have to get double or triple vaccinations to comply with vaccine regulations – a move unprecedented in history. .
‘Unprecedented’ denial of natural immunity
The US Supreme Court recently upheld the vaccine requirement at the Centers for Medicare & Medicaid Services (CMS), a division of the US Department of Health and Human Services. This mandate affects 10.4 million healthcare workers working in 76,000 healthcare facilities,3 There is no exception for people with natural immunity to COVID-19 due to previous infection.
Speaking to Epoch Times, Dr. Scott Atlas, a former White House COVID-19 Task Force adviser, called the SCOTUS ruling “another denial of scientific fact,” adding:4
“The fact that we continue to deny superior protection in people who have recovered, with or without vaccination, compared with vaccinated people who have never been infected… to deny that is simply unprecedented in modern history. The proven fact and decades of basic immunology are somehow negated. If we are a society where leaders are constantly in denial of reality, then I am very concerned about the future of such a society.”
While maintaining vaccine regulation for medical facilities that accept Medicare or Medicaid payments, SCOTUS blocked a White House authorization requiring private companies with 100 or more employees to ensure that member has received a COVID-19 shot or is tested for COVID-19 regularly. – or face high fines.
The Labor Department’s Occupational Safety and Health Administration (OSHA) is said to be responsible for enforcing the rule, which affects more than 80 million US workers.5 Regarding their decision, the court noted:6
“While it is indisputable that Congress has given OSHA the power to regulate occupational hazards, it has not given that agency the power to regulate public health more broadly. Requiring vaccinations for 84 million Americans, chosen simply because they work for employers with more than 100 employees, is certainly in the latter category.”
Despite the repealing of the ban on the private business of vaccines, the White House has called on states and businesses to voluntarily enact sweeping vaccine regulations.7 again ignoring the fact that many people have acquired natural immunity.
World No 1 Novak Djokovic is a prime example – despite having had COVID-19 before and thus acquired natural immunity, he was banned from competing at the Australian Open for failing to qualify. COVID-19 injection.8
Natural COVID-19 immunity is superior to shot-based immunity
Data from New York and California health officials, published in the CDC’s Morbidity and Mortality Weekly Report, shows that people who have previously had COVID-19 are better protected against COVID-19. COVID-19 infection with Delta variant compared with people who have been stabbed. The report states:9
“At the start of the week starting October 3, compared with the rate of COVID-19 cases among unvaccinated individuals without a prior COVID-19 diagnosis, the proportion of cases in vaccinated individuals without no previous COVID-19 diagnosis was 6.2 times (California) and 4.5 times (New York) lower; this rate was significantly lower in both groups with a prior COVID-19 diagnosis, including 29.0 times (California) and 14.7 times lower (New York) among unvaccinated individuals with the diagnosis. prior, and 32.5 times (California) and 19.8 times lower (New York) among those vaccinated with a prior COVID-19 diagnosis.
During the same period, compared with hospitalization rates among unvaccinated individuals without a prior COVID-19 diagnosis, hospitalization rates in California followed a similar pattern. These results demonstrate that vaccination protects against COVID-19 and related hospitalizations, and that survival from a previous infection protects against reinfection and associated hospitalizations.
Importantly, protection from infection is higher after the Delta variant becomes dominant, a time when vaccine-induced immunity for many is reduced by immune evasion and immunodeficiency. reduced immunity”.
In another study,ten Researchers reviewed studies published in PubMed and found that the risk of reinfection with SARS-CoV-2 decreased from 80.5% to 100% in people who had previously had COVID-19. Additional research cited in their review shows:11
- Of the 9,119 people who were previously infected with COVID-19, only 0.7% were re-infected.
- At the Cleveland Clinic in Cleveland, Ohio, the prevalence of COVID-19 in previously uninfected individuals was 4.3 per 100; the incidence of COVID-19 among people who have been previously infected is 0 per 100 people.
- According to an Austrian study, the frequency of hospital admissions due to repeated COVID-19 infections was 5 out of 14,840 people, or 0.03%; The frequency of death from repeated infections is one in 14,840 people, or 0.01%.
Given these findings, the researchers concluded that prior infection should be recorded and recovering patients counseled about their risk of reinfection. They stated:twelfth
“However, given the evidence of immunity to previous SARS-CoV-2 infection, policymakers should consider the possibility that recovery from previous SARS-CoV-2 infection is equivalent to immunity from vaccination for purposes related to participation in public events, businesses and workplaces, or travel requirements. ”
Rarely re-infected by SARS-CoV-2
In a letter to the editor of the New England Journal of Medicine, Dr. Roberto Bertollini of the Department of Public Health in Doha, Qatar, and colleagues estimated the effectiveness of innate immunity against reinfection. by comparing data in national cohorts.
They found that immunity acquired from previous infection was 92.3% effective against reinfection with the beta variant and 97.6% effective against reinfection with the alpha variant.13 Protection persists even a year after the first infection.
Researchers from Ireland14 also conducted a systematic review that included 615,777 people who recovered from COVID-19, with a maximum follow-up of more than 10 months. “Reinfection is an uncommon event,” they note, “…no studies have reported an increased risk of reinfection over time.” The absolute reinfection rate ranges from 0% to 1.1%, while the average reinfection rate is only 0.27%.15,16,17
Another study also revealed similar results. It followed 43,044 people who were positive for SARS-CoV-2 antibodies for up to 35 weeks, and only 0.7% became infected again. When genome sequencing was applied to estimate the risk of reinfection at the population level, this risk was estimated to be 0.1%.18
Again, there was no sign of impaired immunity after seven months of follow-up, the researchers concluded: “Reinfection is rare. Natural infection appears to confer strong protection against reinfection with >90% effectiveness for at least seven months. ”19
Another study from Israel also had researchers question “the need to vaccinate previously infected individuals,” after their analysis revealed similar risks of reinfection. in people with natural or vaccine-induced immunity. Specifically, vaccination has an overall estimated effectiveness in preventing reinfection of 92.8%, compared with 94.8% for innate immunity acquired from prior infection.20
Evidence from the University of Washington School of Medicine also shows that long-term immunity to COVID-19 persists in people who have recovered from the natural infection.21 At both seven and 11 months post infection, most of the participants had bone marrow plasma cells (BMPCs) that secrete antibodies specific for the mutant protein encoded by SARS-CoV-2.
BMPCs are found in similar amounts to those in people who have been vaccinated against tetanus or diphtheria, which is considered to provide long-lasting immunity. Overall, our data provide strong evidence that human SARS-CoV-2 infection strongly establishes two branches of humoral immune memory: long-lived BMPCs, the researchers note. long and memory B cells”.22
This is one of the best evidence available for long-term immunity, because this immune memory is a distinct part of the immune system that is needed for long-term protection, beyond the initial immune response. head for the virus.23
Shoots can be worse after a previous infection
If you already have COVID-19, the injection may pose an even greater risk, so much so that Dr. Hooman Noorchashm, a cardiac surgeon and patient advocate, has repeatedly warned the FDA that it is “dangerous.” clear and current” exists for people who have had COVID-19 and were subsequently vaccinated.24
The problem is that viral antigens remain in your body after you are naturally infected. The immune response that is reactivated by the injection of COVID-19 can cause inflammation in tissues where viral antigens are present. The inner membranes of blood vessels, lungs, and brain may be particularly at risk for such inflammation and damage.25 Writing in the Lancet Journal of Infectious Diseases, the researchers also explain:26
“Some people who have recovered from COVID-19 may not benefit from the COVID-19 vaccine. In fact, one study found that prior COVID-19 was associated with an increased incidence of adverse events following administration of the Comirnaty BNT162b2 mRNA vaccine (Pfizer – BioNTech). In addition, there have been rare reports of serious adverse events following vaccination with COVID-19.”
As it stands, the US CDC continues to push for universal vaccination, despite past infections and innate immunity not considered sufficient to join the growing number of sites requiring it. vaccine passport. This is not the case in Switzerland, where residents who have received a COVID-19 shot in the past 12 months are considered to have the same protection as those who have been vaccinated.27
However, the ultimate goal of a vaccine passport is not simply to track a shot. Your entire identity, including medical history, finances, sexual orientation and more, could soon be stored in a mobile app that is increasingly essential to participating in society. While some may call this convenience, others call it oppression.
You can fight vaccine authorizations and their associated vaccine passports by not supporting establishments that require proof of shot or negative test, while avoiding all identities. Digital passport and vaccine ID are offered as a means of increasing “accessibility” or “convenience”.28
